Like the last time advice was issued on the use of the Oxford-AstraZeneca vaccine, we gathered a vaccine safety expert and a thrombosis/haematology expert to sit on a panel and answer journalists’ questions about the latest on the Oxford AstraZeneca vaccine in the under 40s and rare clotting events.
Speakers included:
Prof Anthony Harnden, Deputy Chair of the Joint Committee on Vaccination and Immunisation
Prof Beverley Hunt, Medical Director of Thrombosis UK, and Professor of Thrombosis and Haemostasis at King’s College London
SMC Roundup on JCVI advice and MHRA response.